Literature DB >> 32931618

Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance.

Florent Artru1,2,3, Xavier Miquet4, Mustapha Azahaf4, Julien Labreuche5, Line Carolle Ntandja Wandji1,2, Géraldine Sergent4, Amélie Nobécourt1,2, Pierre Toumelin1, Guillaume Lassailly1,2, Sébastien Dharancy1,2, Olivier Ernst4, Philippe Mathurin1,2, Alexandre Louvet1,2.   

Abstract

BACKGROUND: Body composition may be modified after improvement of portal hypertension (PHT) by transjugular intrahepatic portosystemic shunt (TIPSS) insertion. AIMS: To evaluate changes in body composition following TIPSS placement, their relationship with radiological TIPSS patency and function, and the predictive value of these parameters
METHODS: We retrospectively included 179 patients with cirrhosis who underwent TIPSS placement in our centre for severe PHT from 2011 to 2017. CT scan-based surveillance was performed at baseline, 1-3 (M1-M3) and 6 months (M6).
RESULTS: The median model for end-stage liver disease (MELD) score was 11.4 (8.8-15.1) and Child-Pugh score 8 (7-9). Only the MELD score (HR 1.14, 95% CI 1.08-1.20) and sarcopenia assessed by transversal right psoas muscle thickness at the umbilical level/height (TPMPT/height) (HR 0.86, 95% CI 0.79-0.96) were independently associated with 6-month mortality on multivariate analysis. After TIPSS insertion, TPMT/height increased from 19 mm/m (baseline) to 19.6 mm/m (M1-M3, P = 0.004) and 21.1 mm/m (M6, P < 0.0001). The improvement and its extent were dependent on the radiological patency and dysfunction of TIPSS. Subcutaneous fat surface (SCFS) increased from 183.4 to 193 cm2 (P < 0.0001) and 229.8 cm2 (P < 0.0001), respectively. We observed a decrease in visceral fat surface (VFS) between baseline and M1-M3 (163.5-140.5 cm2 [P < 0.0001]), but not between M1-M3 and M6 (140.5-141.2 cm2 [P = 0.9]). SCFS and VFS did not seem to be modified by radiological TIPSS patency and dysfunction.
CONCLUSIONS: Sarcopenia is independently associated with 6-month outcome and improves after TIPSS placement, together with an inverse evolution of subcutaneous and visceral fat. TIPSS not only treats PHT but also improves body composition.
© 2020 John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 32931618     DOI: 10.1111/apt.16080

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Stefania Gioia; Lorenzo Ridola; Ludovica Cristofaro; Manuela Merli; Jessica Faccioli; Oliviero Riggio; Silvia Nardelli
Journal:  Liver Int       Date:  2021-09-28       Impact factor: 8.754

2.  Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.

Authors:  Johannes Chang; Pauline Höfer; Nina Böhling; Philipp Lingohr; Steffen Manekeller; Jörg C Kalff; Jonas Dohmen; Dominik J Kaczmarek; Christian Jansen; Carsten Meyer; Christian P Strassburg; Jonel Trebicka; Michael Praktiknjo
Journal:  JHEP Rep       Date:  2022-01-21

3.  Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt.

Authors:  Yao-Wei Bai; Jia-Cheng Liu; Chong-Tu Yang; Ying-Liang Wang; Chao-Yang Wang; Shu-Guang Ju; Chen Zhou; Song-Jiang Huang; Tong-Qiang Li; Yang Chen; Wei Yao; Bin Xiong
Journal:  Eur J Gastroenterol Hepatol       Date:  2022-05-23       Impact factor: 2.586

4.  Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.

Authors:  Florent Artru; Naik Vietti-Violi; Christine Sempoux; Joana Vieira Barbosa; Fabio Becce; Nelly Sah; Astrid Marot; Pierre Deltenre; Eleni Moschouri; Montserrat Fraga; Arnaud Hocquelet; Rafael Duran; Darius Moradpour; Pierre-Emmanuel Rautou; Alban Denys
Journal:  JHEP Rep       Date:  2022-05-25

5.  Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jennifer C Lai; Puneeta Tandon; William Bernal; Elliot B Tapper; Udeme Ekong; Srinivasan Dasarathy; Elizabeth J Carey
Journal:  Hepatology       Date:  2021-09       Impact factor: 17.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.